Dextroamphetamine/Amphetamine
Brand name: Dextroamphetamine-Amphetamine
Rank #300 of 500 drugs by total cost
$38.2M
Total Cost
706,329
Total Claims
$38.2M
Total Cost
25,166
Prescribers
$54
Cost per Claim
38,590
Beneficiaries
729,095
30-Day Fills
$1,520
Avg Cost/Provider
28
Avg Claims/Provider
About Dextroamphetamine/Amphetamine
Dextroamphetamine/Amphetamine (sold as Dextroamphetamine-Amphetamine) was prescribed 706,329 times by 25,166 Medicare Part D providers in 2023, costing the program $38.2M. At $54 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 297 | Varenicline Tartrate (Varenicline Tartrate) | $38.8M | 87,274 |
| 298 | Propranolol Hcl (Propranolol Hcl) | $38.7M | 1,168,547 |
| 299 | Icatibant Acetate (Icatibant) | $38.4M | 831 |
| 300 | Dextroamphetamine/Amphetamine (Dextroamphetamine-Amphetamine) | $38.2M | 706,329 |
| 301 | Nebivolol Hcl (Nebivolol Hcl) | $38.2M | 421,756 |
| 302 | Cinacalcet Hcl (Cinacalcet Hcl) | $37.9M | 76,761 |
| 303 | Risperidone (Risperidone) | $37.4M | 1,480,207 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology